Loading...

ProMIS Neurosciences, Inc.

PMNNASDAQ
Healthcare
Biotechnology
$0.82
$-0.30(-26.79%)

ProMIS Neurosciences, Inc. (PMN) Financial Performance & Statements

Review ProMIS Neurosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
0.00%
Operating Income Growth
-88945.14%
88945.14%
Net Income Growth
15973.70%
15973.70%
Operating Cash Flow Growth
-89.19%
89.19%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-12.07%
12.07%
ROIC
-214.91%
214.91%

ProMIS Neurosciences, Inc. (PMN) Financial Statements

Explore quarterly and annual reports for ProMIS Neurosciences, Inc. stock.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Gross Profit Ratio$0.00$0.00$0.00$0.00
R&D Expenses$4.32M$2.56M$1.63M$2.12M
SG&A Expenses$1.68M$1.87M$1.09M$1.55M
Operating Expenses$6.002M$4.43M$2.71M$3.68M
Total Costs & Expenses$6.002M$4.43M$2.71M$3.68M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$76775.00
Depreciation & Amortization$0.00$13.71M$90047.00$7166.00
EBITDA-$238207.00$9.28M-$2.62M-$3.68M
EBITDA Ratio
Operating Income-$6.002M-$4.43M-$2.71M-$3.68M
Operating Income Ratio
Other Income/Expenses (Net)$5.76M$13.71M$90049.00$41563.00
Income Before Tax-$238207.00$9.28M-$2.62M-$3.64M
Income Before Tax Ratio
Income Tax Expense$0.00$0.00$0.00-$7167.00
Net Income-$238207.00$9.28M-$2.62M-$3.64M
Net Income Ratio
EPS-$0.00$0.31-$0.13-$0.19
Diluted EPS-$0.00$0.31-$0.13-$0.19
Weighted Avg Shares Outstanding$25.92M$30.02M$19.77M$19.53M
Weighted Avg Shares Outstanding (Diluted)$26.46M$30.07M$19.77M$19.53M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;